Dr. Michael Kruer, M.D

NPI: 1366640468
Total Payments
$76,642
2024 Payments
$7,963
Companies
14
Transactions
103

Payment Breakdown by Category

Other$44,275 (57.8%)
Consulting$25,538 (33.3%)
Travel$3,396 (4.4%)
Research$2,138 (2.8%)
Food & Beverage$1,238 (1.6%)
Education$57.50 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $44,275 30 57.8%
Consulting Fee $25,538 7 33.3%
Travel and Lodging $3,396 16 4.4%
Unspecified $2,138 1 2.8%
Food and Beverage $1,238 37 1.6%
Education $57.50 12 0.1%

Payments by Type

General
$74,504
102 transactions
Research
$2,138
1 transactions

Top Paying Companies

Company Total Records Latest Year
PTC Therapeutics, Inc. $50,189 58 $0 (2024)
Neurocrine Biosciences, Inc. $16,348 8 $0 (2023)
ACADIA Pharmaceuticals Inc $3,844 5 $0 (2024)
Merz Pharmaceuticals, LLC $3,588 1 $0 (2021)
Retrophin, Inc. $2,160 6 $0 (2019)
Medtronic USA, Inc. $166.42 3 $0 (2017)
Marinus Pharmaceuticals, Inc. $102.67 3 $0 (2023)
UCB, Inc. $75.35 3 $0 (2023)
Sunovion Pharmaceuticals Inc. $73.01 5 $0 (2019)
EISAI INC. $33.75 2 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $7,963 7 PTC Therapeutics, Inc. ($7,950)
2023 $35,361 49 PTC Therapeutics, Inc. ($16,822)
2022 $11,051 12 PTC Therapeutics, Inc. ($9,175)
2021 $18,813 13 PTC Therapeutics, Inc. ($15,225)
2020 $3.58 4 Travere Therapeutics, Inc. ($3.58)
2019 $81.43 8 Sunovion Pharmaceuticals Inc. ($40.11)
2018 $1,031 3 PTC Therapeutics, Inc. ($1,016)
2017 $2,337 7 Retrophin, Inc. ($2,138)

All Payment Transactions

103 individual payment records from CMS Open Payments — Page 1 of 5

Date Company Product Nature Form Amount Type
10/21/2024 PTC Therapeutics, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,500.00 General
10/21/2024 PTC Therapeutics, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,500.00 General
05/30/2024 ACADIA Pharmaceuticals Inc DAYBUE (Drug) Food and Beverage In-kind items and services $13.30 General
Category: RETT SYNDROME
05/14/2024 PTC Therapeutics, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,500.00 General
04/10/2024 PTC Therapeutics, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,500.00 General
04/09/2024 PTC Therapeutics, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,500.00 General
02/09/2024 PTC Therapeutics, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $450.00 General
11/18/2023 ACADIA Pharmaceuticals Inc DAYBUE (Drug) Consulting Fee Cash or cash equivalent $2,000.00 General
Category: RETT SYNDROME
08/09/2023 PTC Therapeutics, Inc. Consulting Fee Cash or cash equivalent $900.00 General
08/04/2023 ORPHALAN INC CUVRIOR (Drug) Food and Beverage In-kind items and services $27.30 General
Category: Hepatology
07/14/2023 Marinus Pharmaceuticals, Inc. ZTALMY (Drug) Food and Beverage In-kind items and services $38.87 General
Category: SEIZURE DISORDERS
07/12/2023 PTC Therapeutics, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,800.00 General
07/08/2023 ACADIA Pharmaceuticals Inc DAYBUE (Drug) Food and Beverage In-kind items and services $21.34 General
Category: RETT SYNDROME
06/16/2023 Horizon Therapeutics plc UPLIZNA (Drug) Food and Beverage In-kind items and services $14.86 General
Category: UPLIZNA
06/09/2023 ACADIA Pharmaceuticals Inc DAYBUE (Drug) Food and Beverage In-kind items and services $9.09 General
Category: RETT SYNDROME
05/26/2023 UCB, Inc. Nayzilam (Drug) Food and Beverage In-kind items and services $30.77 General
Category: Neurology
05/12/2023 Marinus Pharmaceuticals, Inc. ZTALMY (Drug) Food and Beverage In-kind items and services $34.40 General
Category: SEIZURE DISORDERS
05/05/2023 PTC Therapeutics, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,800.00 General
04/22/2023 PTC Therapeutics, Inc. Travel and Lodging In-kind items and services $85.73 General
04/22/2023 PTC Therapeutics, Inc. Food and Beverage In-kind items and services $39.21 General
04/22/2023 PTC Therapeutics, Inc. Travel and Lodging In-kind items and services $34.99 General
04/22/2023 PTC Therapeutics, Inc. Food and Beverage In-kind items and services $30.19 General
04/22/2023 PTC Therapeutics, Inc. Travel and Lodging In-kind items and services $10.51 General
04/21/2023 PTC Therapeutics, Inc. Food and Beverage In-kind items and services $121.00 General
04/21/2023 PTC Therapeutics, Inc. Food and Beverage In-kind items and services $55.50 General

Research Studies & Clinical Trials

Study Name Company Amount Records
FORT Study Retrophin, Inc. $2,138 1

About Dr. Michael Kruer, M.D

Dr. Michael Kruer, M.D is a Neurodevelopmental Disabilities healthcare provider based in Phoenix, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2007. The National Provider Identifier (NPI) number assigned to this provider is 1366640468.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Kruer, M.D has received a total of $76,642 in payments from pharmaceutical and medical device companies, with $7,963 received in 2024. These payments were reported across 103 transactions from 14 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($44,275).

Practice Information

  • Specialty Neurodevelopmental Disabilities
  • Location Phoenix, AZ
  • Active Since 07/10/2007
  • Last Updated 10/24/2019
  • Taxonomy Code 2084P0005X
  • Entity Type Individual
  • NPI Number 1366640468

Products in Payments

  • Xeomin (Biological) $3,588
  • (810) Chenodal (Drug) $2,138
  • DAYBUE (Drug) $2,044
  • SYNCHROMED (Device) $166.42
  • EMFLAZA (Drug) $137.67
  • ZTALMY (Drug) $102.67
  • Nayzilam (Drug) $75.35
  • APTIOM (Drug) $73.01
  • Fycompa (Drug) $33.75
  • CUVRIOR (Drug) $27.30
  • (820) Cholbam (Drug) $25.84
  • Emflaza (Drug) $16.45
  • VALTOCO (Drug) $15.57
  • UPLIZNA (Drug) $14.86
  • Cholbam (Drug) $1.66

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neurodevelopmental Disabilities Doctors in Phoenix